HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wim J G Oyen Selected Research

Integrins

1/2018In Vivo Characterization of 4 68Ga-Labeled Multimeric RGD Peptides to Image αvβ3 Integrin Expression in 2 Human Tumor Xenograft Mouse Models.
11/2014Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?
5/2013Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wim J G Oyen Research Topics

Disease

136Neoplasms (Cancer)
01/2024 - 12/2002
34Neoplasm Metastasis (Metastasis)
02/2024 - 10/2003
28Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 08/2003
25Infections
01/2018 - 03/2002
20Prostatic Neoplasms (Prostate Cancer)
02/2024 - 06/2011
20Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 08/2004
13Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 09/2003
12Melanoma (Melanoma, Malignant)
03/2016 - 01/2003
11Hypoxia (Hypoxemia)
01/2023 - 08/2006
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 08/2004
10Squamous Cell Carcinoma of Head and Neck
01/2017 - 09/2003
10Inflammation (Inflammations)
07/2014 - 07/2003
8Breast Neoplasms (Breast Cancer)
01/2024 - 10/2010
8Thyroid Neoplasms (Thyroid Cancer)
01/2023 - 11/2006
8Abscess
09/2013 - 03/2002
6Carcinoma (Carcinomatosis)
02/2016 - 10/2004
6Peritoneal Neoplasms
02/2009 - 01/2006
5Thyroid Nodule (Nodule, Thyroid)
01/2023 - 05/2006
5Rheumatoid Arthritis
01/2022 - 02/2003
5Endocarditis
01/2018 - 06/2003
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 05/2010
5Fever (Fevers)
06/2015 - 01/2007
5Reperfusion Injury
12/2009 - 01/2005
4Vasculitis (Vasculitides)
11/2022 - 01/2004
4Lung Neoplasms (Lung Cancer)
01/2022 - 08/2011
4Ovarian Neoplasms (Ovarian Cancer)
12/2014 - 08/2007
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2014 - 09/2007
4Communicable Diseases (Infectious Diseases)
09/2013 - 12/2005
4Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2005 - 05/2003
3Adenocarcinoma
01/2023 - 10/2004
3Disease Progression
01/2021 - 09/2005
3Q Fever (Fever, Q)
01/2018 - 06/2003
3Bacteremia
01/2017 - 08/2010
3Cardiotoxicity
11/2015 - 04/2011
3Necrosis
04/2014 - 04/2011
3Lymphatic Metastasis
12/2013 - 07/2006

Drug/Important Bio-Agent (IBA)

35Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2022 - 01/2004
29Monoclonal AntibodiesIBA
01/2019 - 02/2003
28Peptides (Polypeptides)IBA
01/2018 - 12/2002
23AntigensIBA
01/2023 - 01/2003
21AntibodiesIBA
01/2017 - 03/2003
16Radioisotopes (Radionuclides)IBA
01/2021 - 08/2003
15Carbonic Anhydrase IXIBA
01/2023 - 06/2006
14Proteins (Proteins, Gene)FDA Link
01/2023 - 10/2003
14RadiopharmaceuticalsIBA
08/2021 - 10/2004
13Glucose (Dextrose)FDA LinkGeneric
01/2023 - 08/2004
13G250 monoclonal antibodyIBA
01/2023 - 09/2003
10Somatostatin Receptors (Somatostatin Receptor)IBA
11/2017 - 03/2006
9Biomarkers (Surrogate Marker)IBA
08/2021 - 11/2011
81,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021 - 11/2006
8Bevacizumab (Avastin)FDA Link
01/2017 - 09/2008
8Pentetic Acid (DTPA)FDA LinkGeneric
08/2015 - 09/2003
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 05/2008
6Peptide Receptors (Peptide Receptor)IBA
01/2021 - 03/2006
6Anti-Bacterial Agents (Antibiotics)IBA
01/2015 - 06/2003
5ErbB Receptors (EGF Receptor)IBA
01/2024 - 06/2009
5alovudineIBA
01/2017 - 05/2007
5VaccinesIBA
03/2016 - 04/2009
5Neoplasm Antigens (Tumor Antigens)IBA
03/2016 - 10/2003
5Insulin-Like PeptidesIBA
01/2015 - 12/2011
5fluoromisonidazoleIBA
10/2013 - 08/2006
5teprotumumabIBA
09/2013 - 10/2010
5Carcinoembryonic AntigenIBA
11/2010 - 07/2004
5Leukotriene B4IBA
08/2007 - 01/2004
5Interleukin-8 (Interleukin 8)IBA
03/2007 - 03/2002
4Deoxyglucose (2 Deoxy D glucose)IBA
01/2023 - 10/2004
4Radium-223IBA
01/2023 - 01/2017
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2021 - 03/2006
4Cetuximab (Erbitux)FDA Link
01/2019 - 08/2011
4Fluorine-18IBA
12/2018 - 01/2004
4DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
02/2015 - 04/2010
4HaptensIBA
02/2015 - 03/2003
4Sorafenib (BAY 43-9006)FDA Link
11/2014 - 11/2010
4Cholecystokinin B ReceptorIBA
04/2011 - 11/2006
4pimonidazoleIBA
07/2010 - 10/2005
4AcidsIBA
02/2010 - 09/2003
4Integrin beta3 (GPIIIa)IBA
10/2009 - 11/2006
4Adenosine (Adenocard)FDA LinkGeneric
06/2009 - 01/2005
4DPC11870-11IBA
05/2005 - 07/2003
3IntegrinsIBA
01/2018 - 05/2013
3Therapeutic UsesIBA
01/2017 - 09/2003
3Monophenol Monooxygenase (Tyrosinase)IBA
03/2016 - 04/2009
3LutetiumIBA
01/2016 - 09/2013
3Indium-111IBA
05/2014 - 04/2009
3Oxygen (Dioxygen)IBA
10/2013 - 10/2005

Therapy/Procedure

62Therapeutics
02/2024 - 02/2003
33Radiotherapy
01/2019 - 12/2005
33Radioimmunotherapy
01/2016 - 03/2003
18Drug Therapy (Chemotherapy)
01/2017 - 02/2006
8Immunotherapy
03/2016 - 08/2003
7Castration
02/2024 - 12/2016
7Laparotomy
04/2012 - 11/2006
5Aftercare (After-Treatment)
01/2017 - 10/2006
5Gamma Cameras (Gamma Camera)
04/2009 - 03/2002
5Cytoreduction Surgical Procedures
06/2008 - 02/2006
4Blood Vessel Prosthesis
01/2018 - 12/2010
4Chemoradiotherapy
12/2016 - 04/2013
4Neoadjuvant Therapy
01/2015 - 11/2010
4Intravenous Administration
02/2011 - 07/2004
3Precision Medicine
01/2021 - 12/2018